Benitec Biopharma stock price
베니텍 바이오파머NASDAQ:BNTC · Nasdaq · Healthcare$8.98-6.26%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Benitec Biopharma last closed at $8.98 (-6.26%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -9.2×. Its overall grade ranks 132 of 739 stocks in Healthcare.
About this company
Benitec Biopharma last closed at $8.98 (-6.26%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A · 132/739
Valuation grade A+
Related stocks
- BioMarin PharmaceuticalCompetitor
유전자치료·RNA 기반 희귀질환 치료제 개발에서 경쟁
- Sarepta TherapeuticsCompetitor
희귀 유전질환 및 RNA 치료제 분야의 핵심 경쟁사
- Editas MedicineRelated theme
유전자 편집 치료제 개발이라는 같은 테마
About Benitec Biopharma
- What technical signals does Benitec Biopharma (BNTC) have?
- Benitec Biopharma current technical signals: no active technical signal.
- Is Benitec Biopharma a cup-and-handle pattern?
- No. Benitec Biopharma has no valid Cup signal right now.
- What published figures are available for Benitec Biopharma?
- Market cap: $229.89M. Trailing 12 months PER: -9.2×. Latest quarter PBR: 2.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Benitec Biopharma, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy